Moomoo AI 已提取核心訊息
Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of March 2024, indicating a change of auditor. The company's previous auditor, DNTW Toronto LLP, resigned on February 26, 2024, effective immediately, from auditing the financial statements for the year ended September 30, 2023. There were no disagreements or reportable events between Jin Medical International and DNTW during the period from September 23, 2023, to February 28, 2024. Subsequently, on March 1, 2024, the company's Audit Committee appointed Audit Alliance LLP as the new independent registered public accounting firm. The company confirms that there were no consultations with DNTW regarding any reportable events during the two fiscal years ended December 31, 2023, and 2022, up to the date of the new auditor's appointment. The report was signed by Erqi Wang, Chief Executive Officer of Jin Medical International Ltd., on March 1, 2024.
Jin Medical International Ltd., a foreign private issuer, has filed a report with the United States Securities and Exchange Commission (SEC) for the month of March 2024, indicating a change of auditor. The company's previous auditor, DNTW Toronto LLP, resigned on February 26, 2024, effective immediately, from auditing the financial statements for the year ended September 30, 2023. There were no disagreements or reportable events between Jin Medical International and DNTW during the period from September 23, 2023, to February 28, 2024. Subsequently, on March 1, 2024, the company's Audit Committee appointed Audit Alliance LLP as the new independent registered public accounting firm. The company confirms that there were no consultations with DNTW regarding any reportable events during the two fiscal years ended December 31, 2023, and 2022, up to the date of the new auditor's appointment. The report was signed by Erqi Wang, Chief Executive Officer of Jin Medical International Ltd., on March 1, 2024.
外國私人發行人Jin Medical International Ltd. 已向美國證券交易委員會（SEC）提交了2024年3月的報告，表示更換了核數師。該公司前任核數師DNTW Toronto LLP於2024年2月26日辭職，辭去截至2023年9月30日止年度的財務報表的審計職務，立即生效。在2023年9月23日至2024年2月28日期間，Jin Medical International和DNTW之間沒有分歧或應報告的事件。隨後，該公司的審計委員會於2024年3月1日任命審計聯盟有限責任公司爲新的獨立註冊會計師事務所。該公司證實，截至新核數師任命之日，在截至2023年12月31日和2022年的兩個財政年度中，沒有就任何應報告的事件與DNTW進行過磋商。該報告由金醫療國際有限公司首席執行官王爾奇於2024年3月1日簽署。
外國私人發行人Jin Medical International Ltd. 已向美國證券交易委員會（SEC）提交了2024年3月的報告，表示更換了核數師。該公司前任核數師DNTW Toronto LLP於2024年2月26日辭職，辭去截至2023年9月30日止年度的財務報表的審計職務，立即生效。在2023年9月23日至2024年2月28日期間，Jin Medical International和DNTW之間沒有分歧或應報告的事件。隨後，該公司的審計委員會於2024年3月1日任命審計聯盟有限責任公司爲新的獨立註冊會計師事務所。該公司證實，截至新核數師任命之日，在截至2023年12月31日和2022年的兩個財政年度中，沒有就任何應報告的事件與DNTW進行過磋商。該報告由金醫療國際有限公司首席執行官王爾奇於2024年3月1日簽署。
有用
沒用
